OncLive.com (@onclive) 's Twitter Profile
OncLive.com

@onclive

Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.

ID: 43051682

linkhttp://www.onclive.com calendar_today28-05-2009 05:04:27

110,110K Tweet

46,46K Followers

1,1K Following

OncLive.com (@onclive) 's Twitter Profile Photo
OncLive.com
@onclive

6 months ago

The 6-month PFS rate was 49.0% in the certepetide plus gemcitabine/nab-paclitaxel arm vs 40.8% in the chemotherapy alone arm among patients with untreated metastatic pancreatic ductal adenocarcinoma. ASCO #GI25 #pancsm #oncology hubs.li/Q036HNX90

The 6-month PFS rate was 49.0% in the certepetide plus gemcitabine/nab-paclitaxel arm vs 40.8% in the chemotherapy alone arm among patients with untreated metastatic pancreatic ductal adenocarcinoma. <a href="/ASCO/">ASCO</a> #GI25 #pancsm #oncology hubs.li/Q036HNX90